Search

Your search keyword '"Kang, Ho Won"' showing total 492 results

Search Constraints

Start Over You searched for: Author "Kang, Ho Won" Remove constraint Author: "Kang, Ho Won"
492 results on '"Kang, Ho Won"'

Search Results

5. Current treatment patterns within 1 year after prostate cancer diagnosis in Korean patients over 75 years old: a retrospective multicenter study

8. Differential Urinary Microbiome and Its Metabolic Footprint in Bladder Cancer Patients Following BCG Treatment.

10. Retrospective, Evaluator-Blinded, Pilot and Pivotal Clinical Trials: Assessing the mirCaP Kit (hsv2-miR-H9/has-miR-3659) as a Diagnostic Marker for Prostate Cancer in Patients with PSA Gray Zone Levels

13. COL6A1 expression as a potential prognostic biomarker for risk stratification of T1HG bladder cancer: Unveiling the aggressive nature of a distinct non-muscle invasive subtype

14. COL6A1 expression as a potential prognostic biomarker for risk stratification of T1 high grade bladder cancer: Unveiling the aggressive nature of a distinct non-muscle invasive subtype

25. A hydrophilic Janus-faced separator with functionalized nanocarbon for stable cycling of aqueous Zn-metal batteries.

27. Low preoperative serum cholesterol level is associated with aggressive pathologic features and poor cancer-specific survival in patients with surgically treated renal cell carcinoma

30. PD13-06 UTILITY OF A MOLECULAR SIGNATURE FOR PREDICTING RECURRENCE AND PROGRESSION IN NON-MUSCLE-INVASIVE BLADDER CANCER PATIENTS: COMPARISON WITH THE EORTC, CUETO AND 2021 EAU RISK GROUPS

34. List of Contributors

37. Study on the use of Nanostring nCounter to analyze RNA extracted from formalin-fixed-paraffin-embedded and fresh frozen bladder cancer tissues [Cancer Genetics 268-269 (2022) 137-143]

38. Utility of a Molecular Signature for Predicting Recurrence and Progression in Non-Muscle-Invasive Bladder Cancer Patients: Comparison with the EORTC, CUETO and 2021 EAU Risk Groups

39. Anti-Metastatic Effect of Pyruvate Dehydrogenase Kinase 4 Inhibition in Bladder Cancer via the ERK, SRC, and JNK Pathways

47. Current treatment patterns within 1 year after prostate cancer diagnosis in Korean patients over 75 years old: a retrospective multicenter study

Catalog

Books, media, physical & digital resources